The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kenneth I Ataga, MD
The University of Tennessee Health Science Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Illinois at Chicago
Chicago, Illinois, United States
Santosh Saraf, MDRecruiting - Wake Forest University
Winston-Salem, North Carolina, United States
Payal Desai, MDNot, yet, recruiting - the University of Tennessee Health Science Center
Memphis, Tennessee, United States
Kenneth Ataga, MDLaila Elsherif, PhDMarquita Nelson, MDRobert Davis, MDUgochi Ogu, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jul 2022
- Primary completion
- 31 Jan 2026
- Completion
- 31 Jan 2026
- Last update posted
- 14 Dec 2023
- Registered enrollment
- 400
- Registry id
- NCT05214105
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.